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ABSTRACT 
Objective: The flavonoidal drug Naringenin offers a natural defense against free radical generation due to their antioxidant i.e. free radical 
scavenging property. The continuation of research work towards the invention of targeting the flavonoidal drug for skin carcinoma. Naringenin is a 
potent antioxidant, having remarkable reactive oxygen species scavenging potential and abundantly found in citrus fruits.  
Methods: The optimization of the formulated mannosylated naringenin-loaded transfersomes (MA-NgTfs) was performed using Box–Behnken 
statistical design to obtain crucial variable parameters that influence vesicular size, size distribution and surface charge. Therefore keeping both the 
concepts in mind our objective is to design and optimize the mannosylated naringenin loaded transfersomes (MA-NgTfs) for macropahge targeting. 
The Box Behnken with 3D surface response design graph was employed to optimize the formulation.  
Results: Phospholipids and surfactant ratio played a remarkable role to determine the mean vesicular size and the Zeta potential of the vesicles. 
The Zeta potential is found in the formulation having a range of-18.01±1.05 to-28.7±1.008 mV represents the good stability of the formulation. The 
vesicles size range was found in the range of 102.4±1.01 to 263.74±0.63 and range of Entrapment efficiency of nanovesicles was as 72.04±1.53 to 
82.04±0.81. In vitro drug release study shows that mannosylated naringenin loaded transfersomes (MA-NgTfs), and marketed formulation 
dispersion was found 69.31 %, 62.03 %, 58.71 %, and 65.02 % respectively. Ex vivo skin permeation and deposition study shows that the marketed 
product and pure drug suspension optimized transfersomes through the skin of mice was of flux 6.5±3.07 and the percentage of drug retention was 
0.76±1.26. The results gave us strong evidence of cellular uptake bymannose–directed transfersomes via mannose receptor-based endocytosis. 
Conclusion: On the basis of findings, the study revealed that the prepared formulation has characteristic potential for targeting and the concept of 
ligand directed nanocarrier formulation was imparts synergistic effect against UV-induced skin carcinoma.  
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INTRODUCTION 
Human skin is the largest organ and is highly exposed to 
environmental solar radiation and due to chronic long term 
exposure skin produces abnormal cell growth, which is responsible 
for the progression of skin cancer [1]. The solar radiation is 
composed of various electromagnetic radiation having UV-radiation 
and infrared radiation mainly. From all the three regions the UV-
radiation having the range of (280-320) nm i.e. UVB is having 
remarkable potency to alter the biological function of the cell and 
causes maximum DNA damage due to free radical generation into 
the cells and promotes the abnormal cell growth [2]. Nowadays, 
various drug delivery systems are in the pharmaceutical market, to 
deliver the medicament at the specific site, but due to frequent wear 
and tear of the keratinized layer of skin, the presence of enzymes 
and the lipophilicity of skin membrane, and various contributing 
factors, site-specific drug delivery to the skin is not as easy task as it 
appears to be [3]. The pre-existing conventional therapy has also 
been failed to bring relief because they do not identify the cancerous 
and the normal proliferating cells. Thus the major objective of the 
skin cancer therapy is to develop such type of targeted drug delivery 
system that can able to deliver the medicaments specifically at the 
site of action. The macrophages are expressed into the skin 
keratinocyte and fibroblast due to chronic exposure of UV-radiation 
of the range (280-320 nm) are enhances the macrophage 
production, which may inhibit the p53-dependent apoptotic 
pathway, thereby inducing photocarcinogenesis into the skin. Hence 
the macrophage targeting-based therapeutics could be useful for 
targeting cancerous cell [4]. Mannose receptors are one of the 
receptors which are overexpressed on the surface of the 
macrophage (MMR), while the other MR+cells (i.e. dendritic and 
endothelial cells) and other different lectins with having mannose-
binding activity have been subsequently identified. The 
glycotargeting exploits highly significant interactions of endogenous 
lectins with the moiety of carbohydrates (often with more than one 
carbohydrate) [5]. Functionalization of nanovesicles through the 
conjugation of ligands that are specifically recognized by surface 
receptors on target cells may favor the stimulation of the immune 
system. Targeting of mannose receptors can be achieved by the 
technique of mannosylation, which is an effective strategy to design 
and develop nano-systems that could be able to target mannose 
receptors, which are highly expressed in cells of the immune system 
and can play crucial role in preventing UV radiation caused skin 
carcinoma in which the immunity is hampered directly [6]. The 
flavonoids drug naringenin offers a natural defense against free 
radical generation due to their antioxidant i.e. free radical 
scavenging property. The continuation of research work towards the 
invention of targeting drug delivery systems for skin cancer. Hence 
we proposed the macrophage targeting for skin cancer which may 
be useful for future perspective and effectively used as a site-specific 
drug delivery of Naringenin to the cancerous cells and also decrease 
the adverse effect related to the drug and treat skin carcinoma 
synergistically [7]. Mannose receptor is the most suited receptor to 
formulate the drug delivery system for herbal bioactive and other 
small and macromolecules. The Mannose ligands and their 
associated delivery system are cost-effective and easily affordable to 
use and for future perspective. On the basis of previous findings, a 
formulation based on targeted therapy of natural bioactive for skin 
cancer is yet present in the market; therefore, our objective of the 
study was to conceptualize and formulate the optimized 
mannosylated naringenin loaded transfersomes based formulation 
for targeting macrophages of cancerous cells via Mannose ligand. 
MATERIALS AND METHODS 
Materials 
Naringenin (Ng) was purchased from Sigma Aldrich, USA; D-
Mannosamine HCl was purchased from Himedia Laboratories and 
Soya Phospholipids, Rhodamine, was purchased from Himedia 
Mumbai India. Phosphatidyl-Choline from soy lecithin containing 
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not less than 98% Phosphatidyl Choline, DMSO. Phosphate-buffered 
saline (PBS) (pH 7.4 and pH 5.5) was used for the determination of 
drug release. All other consumables used throughout the experiment 
were of analytical grade.  
Chemicals for cell culture  
The different solvents that were used in the process were of HPLC 
grade. Millipore super Q water system was used for purification of 
water. The National Center for Cell Science, Pune in India provided 
the two cell lines. The 3-(4, 5-Dimethylthiazol-2-yr)-2, 5-
diphenyltetrazolium bromide for (MTT) assay was obtained from 
Sigma Aldrich. HaCaT cells were cultured in Dulbecco’s Modified 
Eagle’s Medium Nutrient Mixture F-12 HAM (DMEM F-12 HAM)with 
2 mmol L-glutamine supplemented with 10% fetal bovine serum 
(FBS), 45 IU/ml penicillin, and 45 IU/ml streptomycin (HaCaT 
media), at 37 °C in 5% CO2
Design of experiment statistics 
. Preparations of mannosylated 
naringenin loaded transfersomes (MA-NgTfs) were formed by slight 
modification with the previously reported method [8]. The total lipid 
content and Tween 80 was mixed in a small amount of chloroform 
the plant active naringenin is about 20 mg and 10 mg of D-
mannosamine HCl was dissolved in ethanol and the whole solution 
was subsequently added into lipid and Tween-80 mixture solution 
the solvent was evaporated at rotary evaporator (Buchi rota vapor 
R-3000 with 14000 water bath, Switzerland) until a dry layer of a 
mixture solution is formed and hydrated with phosphate buffer pH 
(5.5) at the temperature of 45  ᵒC by rotation speed of 70 rpm and 
the nanovesicles forms were allowed to absorb and swell at room 
temperature for 3 hr. The soaked and hydrated prepared 
transfersome formulation was sonicated for 25 min in a probe 
sonicator to uniform and reduce the vesicles size. The developed 
MA-NgTfs were stored in a tightly closed container for performing 
further experiments. 
The Box Behnken Response Surface methodology has been used to 
characteristically identify the influence of three critical and suitable 
formulation variables on vesicular size, % Entrapment efficiency, 
and Zeta potential of the developed (MA-NgTfs). The formulation 
details of the optimization were dictated in table 1. The limit and 
range of every factor were selected according to preliminary 
experiments results and the feasibility of formulating the 
transfersomes at the optimum values [8]. The soya phospholipid: 
surfactant ratio (L: S) % W/W in mg, Rotating Speed (RS) in rpm, 
and sonication time (ST) in min are taken as independent variables, 
whereas the vesicular size (VS) in nm, % Entrapment efficiency 
(%EE), Zeta potential (ZP) in mV, were chosen as dependent 
variables the amount of bioactive Naringenin and ligand (D 
mannosamine HCl) was taken 20 mg and 10 mg respectively and 
kept in constant amount throughout the experiment. The batch code 
and value of all variables coded and actual are shown in table 1. The 
selection of optimized formulation was decided accordingly the 
solution originated by the software. 
Characterization of optimized mannosylated naringenin laded 
transfersomes (O-MA-NgTfs) 
Vesicular size, PDI and zeta potential analysis  
The vesicular diameter of mannosylated transfersomes was 
measured by the help of using Zetasizer instruments (Zetasizer, 
Malvern UK). The unimodal Size distribution was measured on the 
basis of the polydispersity index (PDI) [9]. A small range of PDI is 
considered as homogenous population, and a wider the range 
indicates higher heterogeneity. Zeta Potential indicates the charge in 
the form of electric ions on the surface of the vesicles that indicates 
the physical stability of the vesicular delivery system, was 
determined by using the Malvern Zetasizer 3000 HAS (Malvern 
Instruments, UK) [10]. The vesicular delivery system was diluted by 
ultrapure water just before the experiment. The results of size and 
zeta potential are shown in the. 
Surface morphology study 
The surface morphology of prepared optimized vesicles of 
mannosylated naringenin-loaded transfersomes (O-MA-NgTfs) was 
studied by transmission electron microscope (TEM), (Hitachi J500, 
H7500 Japan) [11]. In the carbon-coated copper grids, the sample of 
MA-NgTfs was placed and staining was done by aq solution of 
phosphor-tungstic acid (1 %) and observed under the microscope in 
an accelerated voltage of 100 kV  
X-Ray diffraction study 
X-ray diffraction study was performed for the analysis of the nature 
of (Crystalline or Amorphous) of mannosylated Naringenin loaded 
transfersomes [12]. Naringenin Soya Lecithin (Phospholipid), D-
Mannosamine HCl physical mixture and transfersomes were carried 
out by using powder X-ray diffractometer (PAN analytical 3KWX’ 
Pert Powder, Cambridge U. K.) followed by the sample of the 
formulation was kept and sputtered out in sample stage and scanned 
for the range of 2Ɵ to 60Ɵ with an accelerating voltage of about 40 
kV and with load current of 30 mA. A Cu-Ka radiation source and 
scanning rate (2 h/min) was 5 ᵒC/min.  
FTIR 
FTIR spectrum is used for the detection of the compatibility aspect of 
active pharmaceutical ingredients (API) and the excipients. FTIR spectra 
of Naringenin, Phospholipids, and D-Mannosamine HCl were determined 
by using (Shimadzu Bruker Alpha-II FTIR) by pellet method. All the 
Excipients and Naringenin was mixed with KBr and pellet was formed 
individually and samples were examined over wave number 4000-400 
cm-1
Differential scanning colorimetry study (DSC) study 
 range [13]. The characteristics peaks that shows the significant 
absorption peaks of the functional group of the drug. 
The study of DSC for the pure drug (Ng), soya phospholipid, D-
mannosamine and formulated optimized formulation (MA-NgTfs) 
were performed using DSC instrument (Perkin Elmer, SOPS, Rajiv 
Gandhi Proudyogiki Vishwavidyalaya, Bhopal India) for each drug 
ligand and excipient the samples amount about 5 mg work kept in 
aluminum pans (Al-crucibles, 40 Al) and sealed. The nitrogen 
atmosphere was created and the props get heated from the range 50 
to 400 °C in a rate of 10 °C. 
Measurement of entrapment efficiency 
The entrapment efficiency of prepared mannosylated transfersomes 
is evaluated by the direct method previously described by [14]. The 
amount of Ng encapsulated in mannosylated transfersomes in each 
formulation is detected by using Eppendorf tubes at low 
temperature. The frozen samples of formulations were centrifuged 
at rpm of 14000 by the help of a centrifuge (Remi Centrifuge model 
5430 R) for a duration of 30 min. after that the supernatant solution 
was investigated for drug loading spectrophotometrically at λmax 
EE %=[NgT-NgS/NgT] X 100 
of 
289 nm by (UV-Spectrophotometer Shimadzu Model UV-1800, 
Tokyo Japan) followed by dilution with phosphate buffer pH 5.5. 
Therefore the % EE and % DL was calculated by the formula  
DL %=[NgT-NgS/NgL] X 100 
Where NgT is the amount of total drug which is added into 
transfersomes system, NgS 
Evaluation of storage stability 
is the amount of drug detected in 
supernatant and NgL total amount of lipid used in the formulation.  
The stability study was determined for the thermodynamic stability 
of the system for determination of the ability of formulated 
formulation to withstand against environmental stress. The changes 
occur in vesicular size and physical visualization of the 
mannosylated Naringenin-loaded transfersomes. 10 ml of the 
formulation was kept at normal 25±2 °C, 60±5 % RH and 
temperature of 40±2 °C, 75±5 % RH. At a certain period of time 
interval i.e. 1, 3 and 6 mo the formulation was examined by vesicular 
Size, % Entrapment Efficiency and Zeta potential [15].  
In vitro release study of drug 
The in vitro release study of MA-NgTfs, NgTfs, pure drug suspension, 
and the marketed formulation was carried out by modified Franz 
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diffusion cell (Mol. Wt. cut off 6000-8000, HI Media Ltd, Mumbai, 
India) separately. The diffusion cell was validated and designed 
prior to while performing the study. The mounted cellophane 
membrane on cell assembly of Franz diffusion with having an area of 
diffusion 2.5 cm2
Cellular uptake studies  
 and the receptor compartment consist about 22.5 
ml of PBS pH 5.5 the receptor fluid stirred 100 rpm with the 
temperature at 37±0.5 °C throughout the experiment. The MA-NgTfs 
was taken at donor compartment membrane [15] and about 2 ml of 
samples aliquot was withdrawn in suitable intervals of time and 
again filled immediately with the equal volume of freshly prepared 
diffusion medium. The release studies have been done in triplicate 
pattern and percentage drug release of the drug has been calculated 
and the graph against % drug release versus time was plotted.  
The HaCaT macrophages cell line was procured from the (National 
centre for cell science, pune) was cultured and maintained as a 
supportive culture media in 96 well-cultured plates having EMEM 
(Eagle’s Minimum Essential medium, low glucose with 
glutamine)supplemented with 10 % FBS and with 1 % antibiotics. After 
incubating overnight in a humidified atmosphere (5 % CO2) in at 37±1 
ᵒC the cells were separated and mechanically adjusted with a required 
concentration of the viable cells (1x105/well), the counting was made by 
the help of a haemocytometer. For the quantitative cellular uptake 
estimation, the cells were treated with the free drug and arrange in 
suspension dissolved in (0.5 % DMSO), NgTfs and MA-NgTfs (5 μ/ml, 
Ng/well) and incubated for 37 ᵒC in the atmosphere for 30 min, for the 
time in hrs 1, 3,6,12 and for 24 h. the medium was removed at each time 
point and PBS 5.5 was used to wash the cells in three-time, and collected 
by trypsinization and at 3000 rpm centrifuged for 3 min decanted 
supernatant re-suspended with the periods and 1 ml of ethanol forming 
vertex for 5 minute for extraction of Ng in ethanolic fraction and the 
resulting lysate found was centrifuged in at 5000 rpm in 5 min and the 
absorbance were recorded of Supernatant at 283 nm using UV visible 
spectrophotometer [16], from the ethanol extract of Naringenin was 
used for the calibration curve. The graph of calibration of ethanol Ng 283 
nm, the Ng amount which is uptaken by cells was determined. The 
cellular uptake of Ng was denoted as micrograms of Ng/105
Ex-vivo permeation study 
 cells. For the 
confirmation of the mannose receptor-mediated uptake of MA-NgTfs, 
the mannose receptor found on the surface of cancerous macrophages 
cells were blocked by the help of using incubation of the cells within a 
sufficient amount of free mannose (0.05 M) for the period of time 1 hr 
just prior to incubation with the free Ng, NgTfs and MA-NgTfs in an 
individual experiment and the cellular uptake was determined after 24 h 
treatment. In this experiment, the amount of Ng 10 μM was used. 
The fully thicker skin of hairless (Swiss albino) mice was taken for 
conducting the Ex vivo skin permeation study of naringenin from 
nanovesicles by the use of fabricated Franz diffusion cell with 
enhanced permeation area having with 2.5 cm2
Skin deposition study 
. Freshly prepared 
phosphate buffer of pΗ 5.5 was filled in the receptor chamber of the 
diffusion cell at 37 ᵒC temperature; the diffusion cell was maintained 
and by magnetic stirrer with a hot plate (Magnetic Stirrer Remie 
equipment) and the receptor chamber was agitated constantly with 
the rpm of 300. In the donor chamber, the nanovesicular 
formulation (MA-NgTfs), consisting of drug naringenin was placed 
gently and at 1, 2, 3, 4, 5, 6, 12, 18 and 24 h and about 5.0 ml of a 
solution containing drug were removed and the concentration of 
drug determined by UV-Spectrophotometer (UV Spectrophotometer 
SHIMADZU, 1800) and was replaced quickly with the same volume 
of freshly prepared PBS having pΗ 5.5. All experiments have been 
done in triplicate. 
The studies of skin retention have been done to determine how 
much the content of bioactive i.e. Naringenin diffuses from the skin 
after 24 h. The skin-bearing diffusion cell was separated carefully 
and the surface of the skin rinsed carefully around 5 times with the 
help of 45 ᵒC receptor chamber medium for the determination of the 
amount of Naringenin in the skin. The small pieces of skin were cut 
from cleaned skin and mashed entirely in a beaker. In this mass 10 
ml of 50% ethanol was added with the help of a water shaker bath. 
The complete extraction of Naringenin has been done by using a 
water shaker bath in 37 ᵒC for 2 hr in a mechanically shaken beaker. 
The appropriate dilutions have been made for the determination of 
Naringenin content in the resulting solution by UV spectroscopy. 
Statistical analysis 
The data and the findings obtained by the optimization were 
expressed in the form of mean±SD (Standard deviation). The results 
found by the analysis were represented as an analysis of variance p-
value less than 0.05, (p˂0.05) considered as significant. The Stat -
Ease, Design Expert trial version 12.0.1.0 was used for the statistical 
data analysis and 3D plotted graph.  
 
Table 1: Box behnken model of actual experimental design and obtained actual responses 
F-
code 































Tfs-1 0 0 0 92:8 60 20 156.2±0.68 79.03±0.96 22.8±0.99 0.229±0.102 9.017±0.019 
Tfs-2 1 0 -1 88:12 60 25 263.74±0.63 74.09±0.63 18.8±0.91 0.385±0.076 7.018±0.009 
Tfs-3 0 1 -1 92:8 70 15 209.81±1.57 77.8±1.15 18.04±1.09 0.135±0.108 3.019±0.028 
Tfs-4 -1 0 -1 96:4 60 15 225.07±1.08 74.81±1.37 18.01±1.05 0.210±0.298 2.321±0.089 
Tfs-5 1 0 1 88:12 60 25 112.3±0.66 79.02±0.99 24.2±0.63 0.543±0.086 8.43±0.19 
Tfs-6 0 1 1 92:8 70 25 102.4±1.01 82.04±0.61 28.7±1.008 0.477±0.017 9.01±0.076 
Tfs-7 0 0 0 92:8 60 20 149.7±1.18 79.8±1.41 25.02±1.19 0.169±0.065 7.026±0.49 
Tfs-8 0 0 0 92:8 60 20 133.8±2.11 81.03±0.60 24.8±2.8 0.229±0.033 6.047±0.048 
Tfs-9 0 0 0 92:8 60 20 165.04±0.58 78.2±2.09 23.09±1.63 0.579±0.210 5.069±0.035 
Tfs-10 1 1 0 88:12 60 20 154.6±1.30 76.4±2.270 23.02±1.77 0.170±0.057 6.047±0.78 
Tfs-11 0 0 0 92:8 60 20 174.8±1.40 78.6±1.43 21.09±1.21 0.212±0.201 7.043±0.056 
Tfs-12 0 -1 -1 92:8 50 15 188.2±0.71 75.2±1.09 19.6±1.50 0.190±0.091 4.046±0.067 
Tfs-13 -1 0 1 96:4 60 25 119.7±1.37 72.04±1.53 25.8±1.93 0.199±0.013 7.01±0.036 
Tfs-14 -1 -1 0 96:4 50 20 198±1.09 73.04±1.45 20.03±1.19 0.389±0.200 6.09±0.082 
Tfs-15 -1 1 0 96:4 70 20 191.7±1.35 74.8±1.58 22.03±1.19 0.140±0.027 5.023±0.098 
Tfs-16 1 -1 0 88:12 50 20 173.02±1.50 73.83±1.48 20.21±1.45 0.212±0.070 6.046±0.019 
Tfs-17 0 -1 1 92:8 50 25 109.8±1.42 79.08±1.85 24.03±1.53 0.280±0.047 8.016±0,02 
*mean±SEM (n = 6). 
 
RESULTS AND DISCUSSION 
Statistical analysis 
The Box-Behnken Model (BBM) with response surface quadratic 
model has been used for the maximum variables at different three 
levels low (-1), medium (0), and high (+1) along with the respective 
limited number of runs. The present research work aimed at the 
investigation of variables viz. Dependent and independent were 
analyzed at 3 levels of factorial design and three responses were 
studied. The 3 different values were found in ranging from for VS, 
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for % EE and ZP. On the basis of data and results, the quadratic 
model was suitable for these responses viz. Mean Vesicular Size 
(VS), Entrapment efficiency (% EE) and zeta potential (ZP). 
The Quadratic equations generated by the software were mentioned 
below:  
(VS), Y1=155.91-3.85X1-1.31X2-55.33X3-3.03X1X2-11.52X1 X3-
7.25X2 X3+25.54X1 2-2.11X2 2-1.24X3
(%EE), Y
2 
2=79.33+1.08 X1+1.24 X2+1.29 X3+0.2025 X1X2+1.92 X1 
X3+0.0900 X2 X3-4.18 X1 2-0.6373 X2 2-0.1647 X3
(ZP), Y
2 
3=23.26+0.0450 X1+0.9900 X2+3.54 X3+0.2025 X1X2-0.5975 
X1 X3+1.56 X2 X3-1.46 X1 2-0.5738 X2 2-0.1937 X3
Where X
2 
1 , X2, and X3 denoted the coded value of the Lipid: Surfactant 
ratio (L: S), X2=Rotating Speed (RS), X3
Response surface plot 
=Sonication time (ST). In the 
equation, all the positive signs represent the synergistic effect on the 
responses, whereas the value of lack of fit is not significant in most 
of cases. The remaining parameters existing with a significant value 
with p-value ≤0.05. The experimental v alue as performed at the 
average of 3 batches (n=3) of transfersome formulation and the 
optimized range closer to the predicted value and on the basis of the 
difference between the predicted value and observed value, the low 
percentage bias were found, which indicates in the table 2 the 
optimization was reasonable and consistent [17]. 
The BBM was employed to find surface responses. The 17 
experimental runs were obtained exclusively for 3 level low (-1), 
medium (0), and high (+1) and three factors. The findings of 
optimization were shown in the table 3 along with both the variables 
independent as well as dependent. Other surface responses were 
plotted. The 3D response surface graph was generated by the help of 
software Design Expert trial version 12.0.1.0 and the value of 
separated other statistical parameter was obtained like the 
coefficient of variation, p-value, standard deviation and predicted F-
value was summarized in with their significant value which was 
shown in the table 3. The graph of 3D surface response Have been 
used for the detection of Interaction pattern the 3D response surface 
plots imparts the information that soya phospholipids: surfactant ratio 
rotating speed and sanitation time significantly exhibited at the mean 
vesicle size, Entrapment efficiency (% EE) and Zeta potential (ZP) with 
the help of software Design expert The independent variable viz the 
ratio of Soya Phospholipids: Surfactant plays a vital role in the 
determination of the size of vesicles (VS) and Entrapment efficiency 
(% EE) the limit of soya phospholipids: surfactant for Entrapment 
efficiency of transfersomes was found in the range of 92:8 the 
justification for Entrapment efficiency (% EE) is that when surfactant 
ratio is in medium concentration were added the Entrapment 
efficiency was found to be optimum in range but slightly increasing the 
ratio of surfactant the Entrapment efficiency (% EE) suddenly 
decreased due to pore formation in the surface and leaking of drug. 
The rotating speed of 70 rpm was considered as good but not affected 
remarkably. The sonication time (ST) is about 25 minute was for small 
vascular size and Entrapment efficiency; the Zeta potential of all 
formulations was in the range of with good stability table 3 indicates 
the suitable polynomial equation with interaction factors which was 
selected for the estimation of several parameters statistics such as the 
adjusted multiple correlations adjusted R square multiple correlation 
Coefficient R square and predicted residual sum of squares generated 
by software design expert 12.0.1.0. 
 
Table 2: Comparison of predicted and observed values in the prepared MA-NgTfs under predicted optimum condition 
Response Prediction  Observation % Bias 
Y1 102.4±1.01  = Vesicle Size (nm) 104.2±0.64 1.75 
Y2 82.04±0.61  = % Entrapment Efficiency 80.07±0.96 2.40 
Y3 -28.7±1.008 = Zeta Potential (-mV) -27.06±3.02 5.75 
% Bias = [(Predicted value–Observed value)/Predicted value] X 100, *
 
mean±SEM (n = 6). 
Table 3: Summary of results found in regression analysis for response and analysis of variance for vesicular size, % entrapment efficiency 
and zeta potential 
Statistical parameters DF SS MS F-value p-value R SD 2 C. V % 
Mean Vesicular Size         
Model 9 28147.40 3127.49 7.61 0.0070Significant 0.9073 20.27 12.19 
Residual 7 2876.54 410.93      
Core total 16 31023.94       
% Entrapment Efficiency         
Model 9 127.17 14.13 8.59 0.0049Significant 0.9170 1.28 1.67 
Residual 7 11.51 1.64      
Core total 16 138.68       
Zeta Potential         
Model 9 130.33 14.48 8.69 0.0047Significant 0.9178 1.29 5.79 
Residual 7 11.67 1.67      
Core total 16 142.00       
DF: Degree of freedom, SS: Sum of Square, R2
 
: Correlation Coefficients, CV: coefficient of variation, SD: Standard Deviation  
Effect of phospholipids and surfactant ratio on the particle size, 
PDI and zeta potential 
The phospholipids and surfactant ratio played a remarkable role to 
determine the mean vesicular size and the Zeta potential of the 
vesicles which required for the stability of the formulation. The 
formulation was designed by using the range of lipid surfactant ratio 
at the range 96:4 %-88:12 % W/W. The drastic size increment was 
made when the lipid surfactant ratio is in increasing order. The Zeta 
potential is found in the formulation having a range of-18.01±1.05 
to-28.7±1.008 mV represents the good stability of the formulation. 
Zeta potential represents the surface charge of the vesicles and 
required for the determination of the stability and L: S ratio play a 
remarkable role in imparting the stability of the nanovesicular 
system. The vesicles size range was found in the range of 102.4±1.01 
to 263.74±0.63 table 1 and the range of Entrapment efficiency of 
nanovesicles was as 72.04±1.53 to 82.04±0.81. The Entrapment 
efficiency of transfersomes was increased significantly (p≤0.05) by 
increasing the ratio of surfactant concentration ranging from 4 to 8 
% W/W for formulated transfersomes prepared using Tween 80 as 
the surfactant.  
Size analysis 
The vesicular size analysis values for optimized transfersomes 
determined by Malvern Zeta sizer showed size ranging from 
Saraf et al. 
Int J App Pharm, Vol 13, Issue 2, 2021, 235-241 
239 
102.4±1.01 to 263.74±0.63 nm table 1. The effect of less lipid ratio of 
phospholipids and surfactant concentrate on the particle size can be 
seen from the particle size of sample Tfs–5 and Tfs–6 (112.3 nm and 
102.4 nm), respectively. The effect of sonication and rotation speed 
was not significant on decreasing the size of the particle separately 
but together, they showed decreases in particle size. Sonication time 
also led to an alteration in the zeta potential of the formulation. On 
increasing the sonication time, zeta potential changes from 18.01 
mV to 28.7 mV. Additionally, there was no significant effect of 
rotation speed on PDI. 
Surface morphological study 
The surface morphology of optimized mannosylated naringenin-
loaded transfersomes (O-MA-NgTfs) is depicted. The tables shows 
that the prepared Mannosylated nanovesicles are nanosized with 
having the single lamella the surface of O-MA-NgTfs are displayed as 
retention and sealed vesicular structure and also indicates the 
uniform homogeneous size distribution.  
X-ray diffraction 
Powder X-ray diffraction patterns of pure Naringenin (Ng), soy 
lecithin, an optimized lyophilized sample of mannosylated naringenin-
loaded Transfersomes were recorded. The Ng showed distinct 
characteristic sharp and intense peaks at 2h values of, and in the 
diffractogram. These peaks indicate that the Ng was crystalline nature. 
These peaks of Ng were absent in Mannosylated Naringenin-loaded 
Transfersomes (MA-NgTfs) diffractogram, which indicates that Ng was 
present in the amorphous form within the transfersomes. If Ng was 
present outside the transfersome, it would occur crystallization 
because its poor aqueous solubility and might be affected the 
diffraction patterns of the Ng-loaded transfersome. But no changes 
occur in diffractogram, which indicates that Ng was successfully 
encapsulated into the transfersome. The X-ray diffraction patterns of 
empty and Ng-loaded transfersome were quite similar, indicating that 
the presence of Ng did not affect the nature of transfersome. In case of 
bulk soya lecithin diffractogram peaks were obtained between 2 h 
values of 14.67–26.56. These peaks were also obtained in empty and 
Ng-loaded transfersome diffractogram but having lower intensity, 
which suggests a less ordered structure of soya lecithin in 
transfersome.  
Differential scanning colorimetric (DSC) study 
At the 251 ᵒC, pure drug naringenin in a sharp melting transition 
point was observed at 77.52 to and 222.13 ᵒC soya 
phosphatidylcholine chlorine and Tween 80. At 218.19 ̊ C, a peak has 
shown by DSC thermogram of optimized formulation it is indicated 
by new sharp melting endothermic peaks of prepared transfersomes 
formulation which is absent initially due to crystalline phase of 
ingredient and the bioactive. The characteristic peak of naringenin 
was completely absent in the case of MA-NgTfs, which indicated the 
incorporation of drug Ng in the lipid system. Therefore it is stated 
that the drug present in the nanocarrier is in the amorphous state 
and due to this, the drug does not show its endothermic peak in the 
optimized formulation. 
FTIR study 
The Fourier transform infrared spectroscopic study of plant 
bioactive Naringenin (Ng) shows the significant peaks recorded by 
the scanning pellets with the range of 500-4000 cm-1. The spectra of 
Ng characteristics bands and peaks at 3326.66 cm-1(Alkenyl C-H 
stretching) 3175.58 cm-1(Alkynyl C-H stretching), 1645.17 cm-
1(carbonyl groups stretching) and 1400-1500 cm-1(Aromatic ring 
C=C bending). The confirmation of conjugation between lipid and 
the D-mannosamine HCl shows the identifying peak at 1600 cm-1and 
the availability of strong sharp peak between 1620 and 1640 cm-1. 
The IR spectrum of Ng ring modes which corresponds to the 
localization of benzene part of the Naringenin, but it is disappeared 
in the case of MA-NgTfs transfersomes formulation. Whereas the 
new and characteristics peaks are recorded at 1550 cm-1C-C 
stretches and 1620 cm-1
In vitro drug release study 
 for aromatic C-H bending. Rest of the peaks 
is either remaining same or slightly shifted in the IR spectrum of the 
formulation. This corroborating the entrapment of drugs and 
conjugation of mannose in the lipid. 
Phosphate buffer saline (pH 7.4) was used as dissolution media and 
the dialysis bag was submerged in 100 ml of media with 100 rpm 
stirring at 37 ᵒC temperature. Subsequently, 1 ml samples were 
withdrawn at definite time-points and the same amount of fresh 
media was added to maintain sink condition. Percentage release of 
samples was estimated at 289 nm using UV spectrophotometer. The 
experiment was performed in triplicate. No drug precipitation was 
observed during release study, as confirmed by the physical 
observation of the dialysis bag. The agenda of Mannosylated 
naringenin-loaded transfersomes to control burst release 
phenomenon by Tfs as well as maintain the sustained duration of 
release. Mannosylated naringenin-loaded transfersomes, and 
marketed formulation dispersion was found 69.31 %, 62.03 %, 
58.71 %, and 65.02 % respectively as shown in fig. 1. The release of 
hydrophobic drug form naringenin is dependent on the diffusion 
ability from the oil core into the surfactant layer and finally to 
continuous phase. The dynamic layer of Mannosylated creates 
additional partition through continuous phase. This leads to slow 
release of drug from the oil core and it could be predicted that it will 
maintain the therapeutic window at the site of action for a longer 
period of time. Therefore, it is expected to obtain a prolonged 
release of incorporated naringenin at the site of application to 
maintain the supply of the therapeutic agent towards effective 
healing of wound. The result is represented in table 4. 
 
Table 4: In vitro drug release profile of optimized mannosylated naringenin loaded transfersomes (O-MA-NgTfs), plain naringenin loaded 
tansfersomes (NgTfs), pure drug suspension (PDS) and marketed formulation (MF) 
S. No. Time 
intervals 
% Cumulative drug release from various formulation 
O-MA-NgTfs NgTfs Marketed formulation (MF) Pure drug suspension (PDS) 
1 0 0 0 0 0 
2 2 9.83±2.14 8.49±1.23 13.52±2.41 14.02±0.32 
3 4 20.17±1.12 18.13±0.41 25.11±1.06 29.43±0.51 
4 6 32.81±1.37 30.02±2.13 37.57±2.03 44.06±2.41 
5 12 48.07±2.71 45.13±1.51 53.31±0.82 60.21±0.83 
6 24 62.03±0.42 58.71±2.53 65.02±0.37 69.31±2.31 
*mean±SEM (n = 6) 
 
Ex vivo skin permeation and skin deposition and study 
The ex vivo permeation study revealed that the cumulative 
concentration of naringenin permeated in Swiss albino mice skin 
through vesicular formulation was significantly higher (p≤ 0.05) 
than the marketed product and pure drug suspension optimized 
transfersomes through the skin of Mice was of flux 6.5±3.07 and the 
percentage of drug retention was 0.76±1.26 whereas the non-
mannosylated Naringenin loaded transfersomes (NgTfs), marketed 
product and pure drug suspension was significantly minimized 
transdermal flux and percent drug retention as shown in table 5. The 
nanosize vesicle range was achieved by the concentration of 
surfactants and the surfactant plays a vital role and act as a 
penetration enhance due to surfactant dilated the layer of skin in the 
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stratum corneum and facilitate to penetrate the vesicles into the intact skin. 
 
Fig. 1: In vitro drug release profile of optimized mannosylated naringenin loaded transfersomes (O-MA-NgTfs) 
 
Table 5: Represented the permeation and % drug retention data for PDS, MF, NgTfs, O-MA-NgTfs across thick skin of (Swiss albino mice) 










% drug retention after 24 h 
/h) 
PDS 5.47±1.51 0.256±2.39 2.01 5.3 .47±0.35 
MF 5.8±2.05 0.243±1.53 1.5 6.7 .56±2.51 
NgTfs 6.03±1.36 0.223±3.47 1.63 7.4 .62±0.57 
O-MA-NgTfs 6.5±3.07 0.221±1.33 1.9 8.2 .76±1.26 
Jss: transdermal flux, P: permeability coefficient, LT: Lag Time, Dd: Diffusion Cofficient and all the values represented as mean±SD (n=3), *
 
mean±SEM 
(n = 6).  
Cellular uptake study 
The estimation of the targeting potential of formulated ligand 
directed delivery system of naringenin could be connected on the 
basis of their targeting potential in macrophages. Therefore the 
cellular uptake of formulated MA-NgTfs was studied in HaCaT 
macrophages cell line [18]. The uptake studies of transferesomes 
have been done in the formulation and plain drug suspension 
(PDS) where one is plain optimized NgTfs and another is optimized 
mannosylated naringenin loaded transfersomes (MA-NgTfs) and 
results revealed that the prominent difference in Naringenin levels. 
The highest amount of drug concentration was observed in 3 h post-
treatment and the level of drug concentration in NgTfs and MA-
NgTfs treated cells 1.51±0.71 μg/105 cells and 2.93±0.48/105μg/105 
cells respectively after 3 h where is the highest concentration of 
drug 2.41±0.51 μg/105 cells was achieved just after 30 min in 
naringenin plain suspension solution. The results threw light the 
concept act that the free naringenin suspension containing 0.5 % 
DMSO rapidly uptaken by HaCaT cells in the 30 min initially after 
that the concentration of the drug decreases rapidly over time and 
level of drug concentration was reduced at 0.01 μg/105 cells after 
the 12 h incubation. In contrast of NgTfs or MA-NgTfs the 
concentration of drug moderately increased in the initial stage (30 
min 3 hr) and during the subsequent time of incubation (3-6 h) was 
reduced. All the concentration of drug in uptake level of MA-NgTfs 
was almost higher than the NgTfs at every time Point (p ≤0.05). The 
outline of results on the basis of finding the reorganization mode of 
MA-NgTfs specific binding to the mannose-specific receptor of 
macrophages which eventually might have uptake their higher 
level. Another parallel experiment was performed for corroboration 
of the experiment previously reported. The mannose receptor 
blocking experiment has conducted the level of the drug from MA-
NgTfs was found significantly in less amount in the blocked cells 
0.81±0.31μg/105 cells as comparatively to unblocked cells. 2.1±0.63 
μg/105
Stability studies 
 cells. Hence the drastic reduction in drug uptake was found 
in blocked cells. The results gave us strong evidence of cellular 
uptake bymannose–directed transfersomes via mannose receptor-
based endocytosis [19, 20]. 
There was a minor increase in the size of the vesicles from nm to 
106.57±0.5 nm to 106.02±0.16 during the condition of storage (40 
ᵒC and 25 ᵒC) for 6 mo and in the stability studies, the optimized 
transfersomes in the initial percent Entrapment efficiency was found 
to be 80.07±0.96 percent and after storing it 6 mo at 40 ᵒC and 25 ᵒC 
it was found to be 76.01±0.53 percent and 76.74±3.36 respectively 
and vice versa for six months at 4 and 25 ᵒC there was no significant 
change in the percent me during the storage of formulation after 
restoring 6 mo Zeta potential at 4 and 25 ᵒC there was a slight 
reduction found for 6 mo at 40 ᵒC and 25 ᵒC temperatures optimized 
formulation was found stable in table 6 data are represented. 
 




Y1 Y = VS (nm) 2 Y =%EE 3= ZP (-mV) 
40±2 °C,75±5 
%RH) 










0 Mo 104.2±0.64 104.2±0.64 80.07±0.96 80.07±0.96 27.06±3.02 27.06±3.02 
1 Mo 104.43±1.92* 104.03±0.45* 79.75±0.48 79.83±2.49** 26.01±0.23 26.81±1.71 
3 Mo 105.05±0.54 105.54±1.28* 77.02±1.58 77.82±0.89** 24.07±1.69 23.87±1.67 
6 Mo 106.57±0.5 106.02±0.16 76.01±0.53 76.74±3.36 23.05±0.76 23.86±0.85 
*mean±SEM (n = 6). Significant at **p<0.01 
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The Designing and optimization of mannose conjugated 
transfersomes have been successfully performed and formulated 
optimized mannosylated Naringenin loaded transfersomes was 
evaluated and the results revealed that the formulated mannose 
directed nano transfersomes has a remarkable capacity for targeting 
the macrophages and the data obtained from the BBM and surface 
response curve was found to be significant. The medium amount of 
lipid and surfactant ratio shows highest entrapment efficiency and 
the highest sonication time i.e. 25 min was required for smaller size 
vesicles which imparts the higher Zeta potential of the formulation it 
provide the thermodynamical stability of vesicular delivery system. 
The FTIR result of optimized MA-NgTfs shows the attachment of D-
mannosamine HCl moiety in the transfersomes. The formulated 
delivery system for skin cancer has the ability to penetrate the skin 
and deposition of naringenin was found to be high concentration 
than the marketed formulation. Therefore the mannose-directed 
transfersomes also improve the dermal delivery of lipophilic 
bioactive. So that the results of our study demonstrated that the 
successful entrapment of bioactive in developed system and their 
targeting affinity towards macrophages. For the authentication of 
macrophage targeting many more studies are still required. 
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